TWiV provides an update on hepatitis of unknown etiology in children, an experimental nanoparticle vaccine for Epstein-Barr virus, and minimal impact of bamlanivimab therapy on antiviral antibodies induced by vaccination.
Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker
Click arrow to play
Download TWiV 911 (76 MB .mp3, 127 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Show notes at microbe.tv/twiv
“Antibody can get vaccinated now”
even Antibody?